Terms: = Leukemia AND TG, Thyroglobulin AND Prognosis
25 results:
1.
Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
[TBL] [Abstract] [Full Text] [Related]
2. Tyrosine Kinase Inhibitor Therapies in Chronic Myeloid leukemia: Effects on Clinical Characteristics and Triglyceride-to-High Density Lipoprotein Cholesterol Ratio.
Erkek ET; Isik AC; Ipek Y; Kul AN
Niger J Clin Pract; 2023 Jun; 26(6):802-809. PubMed ID: 37470656
[TBL] [Abstract] [Full Text] [Related]
3. TG-interacting factor 1 improves risk stratification in patients with NPM1-mutated acute myeloid leukemia.
Tang H; Zhang N; Li H; Chen Y; Liu X; Xiao H; Deng J; Zhou K
Adv Clin Exp Med; 2023 Jul; 32(7):741-751. PubMed ID: 36753372
[TBL] [Abstract] [Full Text] [Related]
4. [The Relationship between Body Mass Index and Adult Acute Myeloid leukemia].
Wang YN; Wei T; Xi YM; Yang MY; Niu L; Wang XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):677-684. PubMed ID: 34105456
[TBL] [Abstract] [Full Text] [Related]
5. Dhx15 regulates zebrafish definitive hematopoiesis through the unfolded protein response pathway.
Cai Y; Wang J; Jin D; Liu Q; Chen X; Pan L; Li Y; Wang X; Qian F; Wang J; Zhong TP; Wang S
Cancer Sci; 2021 Sep; 112(9):3884-3894. PubMed ID: 34077586
[TBL] [Abstract] [Full Text] [Related]
6. B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.
Asslaber D; Qi Y; Maeding N; Steiner M; Denk U; Höpner JP; Hartmann TN; Zaborsky N; Greil R; Egle A
Blood; 2019 Nov; 134(20):1717-1729. PubMed ID: 31537531
[TBL] [Abstract] [Full Text] [Related]
7. Association of IL-27 rs153109 and rs17855750 Polymorphisms with Risk and Response to Therapy in Acute Lymphoblastic leukemia.
Ghavami A; Fathpour G; Amirghofran Z
Pathol Oncol Res; 2018 Jul; 24(3):653-662. PubMed ID: 28828696
[TBL] [Abstract] [Full Text] [Related]
8. Amlexanox Downregulates S100A6 to Sensitize
Tamai H; Yamaguchi H; Miyake K; Takatori M; Kitano T; Yamanaka S; Yui S; Fukunaga K; Nakayama K; Inokuchi K
Cancer Res; 2017 Aug; 77(16):4426-4433. PubMed ID: 28646023
[TBL] [Abstract] [Full Text] [Related]
9. Interleukin-23 Receptor Gene Variants in Acute Lymphoblastic leukemia and Their Relation to Prognostic Factors.
Zareinejad M; Samiei A; Valibeigi B; Gholami T; Zareifar S; Amirghofran Z
Iran J Immunol; 2017 Mar; 14(1):59-72. PubMed ID: 28341819
[TBL] [Abstract] [Full Text] [Related]
10. Establishment of a congenital amegakaryocytic thrombocytopenia model and a thrombocyte-specific reporter line in zebrafish.
Lin Q; Zhang Y; Zhou R; Zheng Y; Zhao L; Huang M; Zhang X; Leung AYH; Zhang W; Zhang Y
Leukemia; 2017 May; 31(5):1206-1216. PubMed ID: 27811851
[TBL] [Abstract] [Full Text] [Related]
11. MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis.
Benner A; Mansouri L; Rossi D; Majid A; Willander K; Parker A; Bond G; Pavlova S; Nückel H; Merkel O; Ghia P; Montserrat E; Kaderi MA; Rosenquist R; Gaidano G; Dyer MJ; Söderkvist P; Linderholm M; Oscier D; Tvaruzkova Z; Pospisilova S; Dührsen U; Greil R; Döhner H; Stilgenbauer S; Zenz T;
Haematologica; 2014 Aug; 99(8):1285-91. PubMed ID: 25082786
[TBL] [Abstract] [Full Text] [Related]
12. Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.
Ho AL; Grewal RK; Leboeuf R; Sherman EJ; Pfister DG; Deandreis D; Pentlow KS; Zanzonico PB; Haque S; Gavane S; Ghossein RA; Ricarte-Filho JC; Domínguez JM; Shen R; Tuttle RM; Larson SM; Fagin JA
N Engl J Med; 2013 Feb; 368(7):623-32. PubMed ID: 23406027
[TBL] [Abstract] [Full Text] [Related]
13. T-cell receptor diversity prevents T-cell lymphoma development.
Newrzela S; Al-Ghaili N; Heinrich T; Petkova M; Hartmann S; Rengstl B; Kumar A; Jäck HM; Gerdes S; Roeder I; Hansmann ML; von Laer D
Leukemia; 2012 Dec; 26(12):2499-507. PubMed ID: 22643706
[TBL] [Abstract] [Full Text] [Related]
14. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
Liu ZM; Tseng JT; Hong DY; Huang HS
Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
[TBL] [Abstract] [Full Text] [Related]
15. [Clinical characteristics of hepatic veno-occlusive disease in 6 children with hematologic neoplasm treated with 6-thioguanine].
Wang HS; Gao YJ; Li J; Lu FJ; Miao H; Qian XW; Zhu XF
Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):708-10. PubMed ID: 21092535
[TBL] [Abstract] [Full Text] [Related]
16. Follow-up of thyroid cancer patients with "poor prognosis".
Toubert ME
Ann Endocrinol (Paris); 2003 Feb; 64(1):68-71. PubMed ID: 12707640
[TBL] [Abstract] [Full Text] [Related]
17. [Role of iodine-131 in the management of differentiated thyroid cancers (vesicular origin)].
Boughattas S; Hassine H; Chatti K; Letaief B; Jomaa R; Essabbah H
Tunis Med; 2002 Aug; 80(8):434-44. PubMed ID: 12703121
[TBL] [Abstract] [Full Text] [Related]
18. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.
Pieters R; den Boer ML; Durian M; Janka G; Schmiegelow K; Kaspers GJ; van Wering ER; Veerman AJ
Leukemia; 1998 Sep; 12(9):1344-8. PubMed ID: 9737681
[TBL] [Abstract] [Full Text] [Related]
19. Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.
Pieters R; Huismans DR; Loonen AH; Peters GJ; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
Leuk Res; 1992 Sep; 16(9):873-80. PubMed ID: 1405718
[TBL] [Abstract] [Full Text] [Related]
20. Hypoxanthine-guanine phosphoribosyl-transferase in childhood leukemia: relation with immunophenotype, in vitro drug resistance and clinical prognosis.
Pieters R; Huismans DR; Loonen AH; Peters GJ; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
Int J Cancer; 1992 May; 51(2):213-7. PubMed ID: 1568789
[TBL] [Abstract] [Full Text] [Related]
[Next]
